Efficacy of MitraClip and continued multidisciplinary cardiac rehabilitation in preventing readmission of an older heart failure patient with severe multivalvular disease: A case report

Published:September 28, 2022DOI:


      The recommendations for the treatment of heart failure patients with severe multivalvular disease are not clear. We present a successful case of an older patient with heart failure and severe multivalvular disease in whom rehospitalization was prevented by a combination of MitraClip implantation (Abbott Vascular, Santa Clara, CA, USA) and continued multidisciplinary cardiac rehabilitation. An 85-year-old male patient presented with New York Heart Association (NYHA) class III severe mitral regurgitation (MR), severe aortic valve regurgitation (AR), and severe tricuspid valve regurgitation (TR). As first choice of treatment, surgical double valve replacement and tricuspid annuloplasty were considered. However, considering his age, pre-frailty condition, risks of surgery, and the desire of the patient, the heart team percutaneously implanted the MitraClip system. After implantation of one MitraClip (placed centrally on the A2/P2 scallops), the severity of the patient's MR decreased to mild from moderate-severe. He was followed up with multidisciplinary inpatient care and outpatient cardiac rehabilitation. At 1 year follow-up, he remained in stable condition at NYHA class I, and echocardiography at this time revealed moderate MR and TR and severe AR, and he has not required hospital readmission.

      Learning objective

      This case report showed that a combination of MitraClip implantation (Abbott Vascular, Santa Clara, CA, USA) and continued multidisciplinary cardiac rehabilitation may be effective in preventing readmission in older patients with heart failure and severe multivalvular disease.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiology Cases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Erlebach M.
        • Lange R.
        Multivalvular disease: percutaneous management in 2019 and beyond.
        Interv Cardiol. 2019; 14: 142-146
        • Feldman T.
        • Kar S.
        • Rinaldi M.
        • Fail P.
        • Hermiller J.
        • Smalling R.
        • Whitlow P.L.
        • Gray W.
        • Low R.
        • Herrmann H.C.
        • Lim S.
        • Foster E.
        • Glower D.
        • EVEREST Investigators
        Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.
        J Am Coll Cardiol. 2009; 54: 686-694
        • Stone G.W.
        • Lindenfeld J.
        • Abraham W.T.
        • Kar S.
        • Lim D.S.
        • Mishell J.M.
        • Whisenant B.
        • Grayburn P.A.
        • Rinaldi M.
        • Kapadia S.R.
        • Rajagopal V.
        • Sarembock I.J.
        • Brieke A.
        • Marx S.O.
        • Cohen D.J.
        • et al.
        Transcatheter mitral-valve repair in patients with heart failure.
        N Engl J Med. 2018; 379: 2307-2318
        • Kamiya K.
        • Sato Y.
        • Takahashi T.
        • Tsuchihashi-Makaya M.
        • Kotooka N.
        • Ikegame T.
        • Takura T.
        • Yamamoto T.
        • Nagayama M.
        • Goto Y.
        • Makita S.
        • Isobe M.
        Multidisciplinary cardiac rehabilitation and long-term prognosis in patients with heart failure.
        Circ Heart Fail. 2020; 13e006798
        • Izawa H.
        • Yoshida T.
        • Ikegame T.
        • Izawa K.P.
        • Ito Y.
        • Okamura H.
        • Osada N.
        • Kinugawa S.
        • Kubozono T.
        • Kono Y.
        • Kobayashi K.
        • Nishigaki K.
        • Higo T.
        • Hirashiki A.
        • Miyazawa Y.
        • et al.
        Standard cardiac rehabilitation program for heart failure.
        Circ J. 2019; 83: 2394-2398
        • Dabiri Y.
        • Yao J.
        • Sack K.L.
        • Kassab G.S.
        • Guccione J.M.
        Tricuspid valve regurgitation decreases after MitraClip implantation: fluid structure interaction simulation.
        Mech Res Commun. 2019; 97: 96-100
        • Hahn R.T.
        • Asch F.
        • Weissman N.J.
        • Grayburn P.
        • Kar S.
        • Lim S.
        • Ben-Yehuda O.
        • Shahim B.
        • Chen S.
        • Liu M.
        • Redfors B.
        • Medvedofsky D.
        • Puri R.
        • Kapadia S.
        • Sannino A.
        • et al.
        Impact of tricuspid regurgitation on clinical outcomes: the COAPT trial.
        J Am Coll Cardiol. 2020; 76: 1305-1314
        • Lauretani F.
        • Russo C.R.
        • Bandinelli S.
        • Bartali B.
        • Cavazzini C.
        • Iorio A.D.
        • Corsi A.M.
        • Rantanen T.
        • Guralnik J.M.
        • Ferrucci L.
        Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia.
        J Appl Physiol. 2003; 95: 1851-1860
        • Lo A.X.
        • Donnelly J.P.
        • McGwin Jr., G.
        • Bittner V.
        • Ahmed A.
        • Brown C.J.
        Impact of gait speed and instrumental activities of daily living on all-cause mortality in adults ≥65 years with heart failure.
        Am J Cardiol. 2015; 115: 797-801
        • Hadaya J.
        • Tran Z.
        • Sanaiha Y.
        • Aguayo E.
        • Dobaria V.
        • Calfon Press M.
        • Benharash P.
        Impact of frailty on short term outcomes, resource use, and readmissions after transcatheter mitral valve repair: a national analysis.
        PLoS One. 2021; 16e0259863